Search Results - "Ohwada, Jun"

Refine Results
  1. 1
  2. 2

    Discovery and biological activity of a novel class I PI3K inhibitor, CH5132799 by Ohwada, Jun, Ebiike, Hirosato, Kawada, Hatsuo, Tsukazaki, Masao, Nakamura, Mitsuaki, Miyazaki, Takuya, Morikami, Kenji, Yoshinari, Kiyoshi, Yoshida, Miyuki, Kondoh, Osamu, Kuramoto, Shino, Ogawa, Kotaro, Aoki, Yuko, Shimma, Nobuo

    Published in Bioorganic & medicinal chemistry letters (15-03-2011)
    “…An orally available, potent class I PI3K inhibitor, CH5132799, was discovered by structure-based drug design. Phosphatidylinositol 3-kinase (PI3K) is a lipid…”
    Get full text
    Journal Article
  3. 3

    In vitro activity of isavuconazole against 140 reference fungal strains and 165 clinically isolated yeasts from Japan by Yamazaki, Toshikazu, Inagaki, Yukiko, Fujii, Toshihiko, Ohwada, Jun, Tsukazaki, Masao, Umeda, Isao, Kobayashi, Kazuko, Shimma, Nobuo, Page, Malcolm G.P, Arisawa, Mikio

    “…Abstract The in vitro susceptibilities of 140 laboratory reference strains of fungi, including type strains, and 165 clinical yeast isolates from Japan towards…”
    Get full text
    Journal Article
  4. 4
  5. 5

    Synthesis of novel water soluble benzylazolium prodrugs of lipophilic azole antifungals by Ohwada, Jun, Murasaki, Chikako, Yamazaki, Toshikazu, Ichihara, Shigeyasu, Umeda, Isao, Shimma, Nobuo

    Published in Bioorganic & medicinal chemistry letters (07-10-2002)
    “…Water soluble N-benzyltriazolium or N-benzylimidazolium salt type prodrugs of several highly lipophilic triazole or imidazole antifungals have been…”
    Get full text
    Journal Article
  6. 6
  7. 7
  8. 8

    Modification of a dihydropyrrolopyrimidine phosphoinositide 3-kinase (PI3K) inhibitor to improve oral bioavailability by Kawada, Hatsuo, Ebiike, Hirosato, Tsukazaki, Masao, Yamamoto, Shun, Koyama, Kohei, Nakamura, Mitsuaki, Morikami, Kenji, Yoshinari, Kiyoshi, Yoshida, Miyuki, Ogawa, Kotaro, Shinma, Nobuo, Tsukuda, Takuo, Ohwada, Jun

    Published in Bioorganic & medicinal chemistry (15-12-2015)
    “…[Display omitted] Phosphoinositide 3-kinase (PI3K) is activated in various human cancer cells and well known as a cancer therapy target. We previously reported…”
    Get full text
    Journal Article
  9. 9

    Design and evaluation of azaindole-substituted N-hydroxypyridones as glyoxalase I inhibitors by Chiba, Takashi, Ohwada, Jun, Sakamoto, Hiroshi, Kobayashi, Takamitsu, Fukami, Takaaki A., Irie, Machiko, Miura, Takaaki, Ohara, Kazuhiro, Koyano, Hiroshi

    Published in Bioorganic & medicinal chemistry letters (15-12-2012)
    “…We conducted a high throughput screening for glyoxalase I (GLO1) inhibitors and identified 4,6-diphenyl-N-hydroxypyridone as a lead compound. Using a binding…”
    Get full text
    Journal Article
  10. 10
  11. 11
  12. 12

    Abstract B157: Selective class I PI3K inhibitor CH5132799 induces significant tumor regression with suppressing 4E-BP1 phosphorylation by Tanaka, Hiroshi, Yoshida, Miyuki, Tanimura, Hiromi, Ohwada, Jun, Ishii, Nobuya, Kondoh, Osamu, Aoki, Yuko

    Published in Molecular cancer therapeutics (12-11-2011)
    “…Abstract The phosphatidylinositol 3-kinase (PI3K) pathway plays a central role in cell proliferation and survival in human cancer. Mutations of the PIK3CA…”
    Get full text
    Journal Article
  13. 13

    SYNTHESIS AND STRUCTURE-ACTIVITY RELATIONSHIPS OF A NOVEL ANTIFUNGAL AGENT, AZOXYBACILIN by OHWADA, Jun, UMEDA, Isao, ONTSUKA, Hitomi, AOKI, Yuhko, SHIMMA, Nobuo

    “…A new antifungal substance, azoxybacilin (an unusual amino acid with an azoxy moiety) and its derivatives have been synthesized from Boc-L-Asp-OtBu utilizing…”
    Get full text
    Journal Article
  14. 14
  15. 15
  16. 16
  17. 17
  18. 18
  19. 19
  20. 20